Univariate analysis | Model 1c | Model 2d | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
N (%) | ORa | 95 % CIb | P | ORa | 95 % CIb | P | ORa | 95 % CIb | P | |
Age (years)e | 1.87 | 1.71–2.04 | ** | 1.98 | 1.81–2.17 | ** | 1.85 | 1.68–2.04 | ** | |
Anthropometric measurements | ||||||||||
Body mass index (BMI) | ||||||||||
C1 < 25.0 | 3990 (72.2) | Reference | Reference | |||||||
25.0 ≤ C2 < 27.5 | 1040 (18.8) | 2.11 | 1.71–2.60 | ** | 2.10 | 1.72–2.56 | ** | |||
27.5 ≤ C3 < 30.0 | 331 (6.0) | 2.25 | 1.63–3.10 | ** | 2.37 | 1.75–3.23 | ** | |||
30.0 ≤ C4 | 166 (3.0) | 2.67 | 1.76–4.06 | ** | 3.46 | 2.34–5.12 | ** | |||
Waist circumference (cm) | ||||||||||
C1 < 85 | 2614 (47.3) | Reference | Reference | |||||||
85 ≤ C2 < 90 | 1419 (25.7) | 1.51 | 1.20–1.90 | ** | 1.40 | 1.10–1.78 | ** | |||
90 ≤ C3 < 95 | 833 (15.1) | 1.73 | 1.14–2.25 | ** | 1.55 | 1.17–2.03 | ** | |||
95 ≤ C4 | 661 (12.0) | 2.65 | 2.06–3.41 | ** | 2.51 | 1.92–3.30 | ** | |||
% Forced expiratory volume in 1 s (%FEV1.0 < 70) | 59 (1.1) | 8.50 | 5.05–14.30 | ** | 5.74 | 3.65–9.01 | ** | 6.96 | 3.97–12.21 | ** |
Atherosclerotic complications | ||||||||||
Cardiovascular disease (present) | 94 (1.7) | 2.16 | 1.27–3.68 | ** | 1.18 | 0.70–1.98 | 1.11 | 0.62–1.97 | ||
Cerebrovascular disease (present) | 29 (0.5) | 5.14 | 2.38–11.11 | ** | 2.08 | 0.93–4.65 | 2.11 | 0.89–5.00 | ||
Medical histories | ||||||||||
Antihypertensive drug use (yes) | 631 (11.4) | 2.53 | 2.02–3.17 | ** | 1.21 | 0.96–1.53 | 1.36 | 1.05–1.75 | * | |
Antidiabetic drug use (yes) | 149 (2.7) | 1.98 | 1.28–3.08 | ** | 1.16 | 0.76–1.77 | 1.16 | 0.72–1.85 | ||
Antidyslipidemic drug use (yes) | 277 (5.0) | 2.00 | 1.44–2.79 | ** | 1.31 | 0.95–1.81 | 1.24 | 0.87–1.77 | ||
Healthy lifestyle characteristics | ||||||||||
Smoking behavior (non-current smoker) | 3505 (63.4) | 0.69 | 0.57–0.83 | ** | 0.58 | 0.48–0.69 | ** | 0.55 | 0.46–0.67 | ** |